The process for regulating CBD was dealt another setback Tuesday with the resignation of Dr. Amy Abernethy from the U.S. Food and Drug Administration, who will leave the agency in mid- to late-April according to a memo from acting FDA Commissioner Janet Woodcock.
Key FDA official, CBD task force leader Amy Abernethy resigns is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs
From Key FDA official, CBD task force leader Amy Abernethy resigns on CBD Products & CBD Business News – Hemp Industry Daily.
This was autoposted by IFTTT. To find out more, read my post about news articles.
No comments:
Post a Comment